National HealthCare Corp. Hits New 52-Week High of $213.19

National HealthCare Corp. has reached a significant milestone by hitting a new 52-week high of USD 213.19 on June 30, 2026. This achievement underscores the company's strong performance in the hospital industry, particularly notable given its market capitalization of USD 2.5 billion, categorizing it as a small-cap stock. Over the past year, National HealthCare Corp. has demonstrated impressive growth, with a remarkable 157.79% increase in stock price, significantly outperforming the S&P 500, which saw a gain of 20.86% during the same period. The company's price-to-earnings (P/E) ratio stands at 21.00, indicating a robust valuation relative to its earnings. Additionally, National HealthCare Corp. offers a dividend yield of 1.56%, reflecting its commitment to returning value to shareholders. The company's financial health is further illustrated by a negative debt-to-equity ratio of -0.29 and a return on equity of 10.96%, showcasing effective management of resources. The stock's previous 52-week low was recorded at USD 93.54, highlighting the significant upward trajectory it has experienced.